These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1349 related articles for article (PubMed ID: 18036033)
1. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients. Lin SC; Chen KH; Lin CH; Kuo CC; Ling QD; Chan CH Eur J Clin Invest; 2007 Dec; 37(12):987-96. PubMed ID: 18036033 [TBL] [Abstract][Full Text] [Related]
2. Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus. Zhang B; Zhang X; Tang FL; Zhu LP; Liu Y; Lipsky PE Ann Rheum Dis; 2008 Jul; 67(7):1037-40. PubMed ID: 18199598 [TBL] [Abstract][Full Text] [Related]
3. The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FoxP3+ regulatory T cells during repeated plasmapheresis treatments of patients. Baráth S; Soltész P; Kiss E; Aleksza M; Zeher M; Szegedi G; Sipka S Autoimmunity; 2007 Nov; 40(7):521-8. PubMed ID: 17966042 [TBL] [Abstract][Full Text] [Related]
4. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells. Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820 [TBL] [Abstract][Full Text] [Related]
5. Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis. Bonelli M; von Dalwigk K; Savitskaya A; Smolen JS; Scheinecker C Ann Rheum Dis; 2008 May; 67(5):664-71. PubMed ID: 17728327 [TBL] [Abstract][Full Text] [Related]
6. Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus. Suen JL; Li HT; Jong YJ; Chiang BL; Yen JH Immunology; 2009 Jun; 127(2):196-205. PubMed ID: 18800986 [TBL] [Abstract][Full Text] [Related]
7. Elevated circulating CD4+ ICOS+ Foxp3+ T cells contribute to overproduction of IL-10 and are correlated with disease severity in patients with systemic lupus erythematosus. Liu Y; Zhu T; Cai G; Qin Y; Wang W; Tang G; Zhao D; Shen Q Lupus; 2011 May; 20(6):620-7. PubMed ID: 21558138 [TBL] [Abstract][Full Text] [Related]
8. Regulatory T cells in patients with systemic lupus erythematosus. Alvarado-Sánchez B; Hernández-Castro B; Portales-Pérez D; Baranda L; Layseca-Espinosa E; Abud-Mendoza C; Cubillas-Tejeda AC; González-Amaro R J Autoimmun; 2006 Sep; 27(2):110-8. PubMed ID: 16890406 [TBL] [Abstract][Full Text] [Related]
9. Accumulation of FoxP3-expressing CD4+CD25+ T cells with distinct chemokine receptors in synovial fluid of patients with active rheumatoid arthritis. Jiao Z; Wang W; Jia R; Li J; You H; Chen L; Wang Y Scand J Rheumatol; 2007; 36(6):428-33. PubMed ID: 18092263 [TBL] [Abstract][Full Text] [Related]
10. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Lee JH; Wang LC; Lin YT; Yang YH; Lin DT; Chiang BL Immunology; 2006 Feb; 117(2):280-6. PubMed ID: 16423064 [TBL] [Abstract][Full Text] [Related]
11. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus. Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711 [TBL] [Abstract][Full Text] [Related]
12. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus. Kuhn A; Beissert S; Krammer PH Arch Dermatol Res; 2009 Jan; 301(1):71-81. PubMed ID: 18985367 [TBL] [Abstract][Full Text] [Related]
13. Role of new population of peripheral CD11c(+)CD8(+) T cells and CD4(+)CD25(+) regulatory T cells during acute and remission stages in rheumatoid arthritis patients. Kao JK; Hsue YT; Lin CY J Microbiol Immunol Infect; 2007 Oct; 40(5):419-27. PubMed ID: 17932602 [TBL] [Abstract][Full Text] [Related]
14. Serum cortisol reduction and abnormal prolactin and CD4+/CD8+ T-cell response as a result of controlled exercise in patients with rheumatoid arthritis and systemic lupus erythematosus despite unaltered muscle energetics. Pool AJ; Whipp BJ; Skasick AJ; Alavi A; Bland JM; Axford JS Rheumatology (Oxford); 2004 Jan; 43(1):43-8. PubMed ID: 12867581 [TBL] [Abstract][Full Text] [Related]
15. Expression of intracellular transforming growth factor-beta1 in CD4+CD25+ cells in patients with systemic lupus erythematosus. Lu LY; Chu JJ; Lu PJ; Sung PK; Hsu CM; Tseng JC J Microbiol Immunol Infect; 2008 Apr; 41(2):165-73. PubMed ID: 18473105 [TBL] [Abstract][Full Text] [Related]
16. Expression of costimulatory molecule CD80 on peripheral blood T cells in patients with systemic lupus erythematosus. Takasaki Y; Ogaki M; Abe K; Takeuchi K; Ando S; Tokano Y; Kobayashi S; Sekigawa I; Tsuda H; Hashimoto H J Rheumatol; 1998 Jun; 25(6):1085-91. PubMed ID: 9632068 [TBL] [Abstract][Full Text] [Related]
17. Anti-DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients. Hahn BH; Anderson M; Le E; La Cava A Arthritis Rheum; 2008 Aug; 58(8):2488-97. PubMed ID: 18668553 [TBL] [Abstract][Full Text] [Related]
18. FOXP3 expression in blood, synovial fluid and synovial tissue during inflammatory arthritis and intra-articular corticosteroid treatment. Raghavan S; Cao D; Widhe M; Roth K; Herrath J; Engström M; Roncador G; Banham AH; Trollmo C; Catrina AI; Malmström V Ann Rheum Dis; 2009 Dec; 68(12):1908-15. PubMed ID: 19066178 [TBL] [Abstract][Full Text] [Related]
19. CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Möttönen M; Heikkinen J; Mustonen L; Isomäki P; Luukkainen R; Lassila O Clin Exp Immunol; 2005 May; 140(2):360-7. PubMed ID: 15807863 [TBL] [Abstract][Full Text] [Related]
20. Expansion of FOXP3-positive CD4+CD25+ T cells associated with disease activity in atopic dermatitis. Ito Y; Adachi Y; Makino T; Higashiyama H; Fuchizawa T; Shimizu T; Miyawaki T Ann Allergy Asthma Immunol; 2009 Aug; 103(2):160-5. PubMed ID: 19739430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]